# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001213900-19-016813
Filing Date
2019-08-27
Accepted
2019-08-27 17:00:27
Documents
4
Period of Report
2019-08-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 8-K | f8k082719_inmunebio.htm | 8-K | 17232
2 | INMUNE BIO INVESTOR FACT SHEET | f8k082719ex99-1_inmunebio.htm | EX-99.1 | 9701
3 | GRAPHIC | ex99-1_001.jpg | GRAPHIC | 449938
4 | GRAPHIC | ex99-1_002.jpg | GRAPHIC | 419627
| Complete submission text file | 0001213900-19-016813.txt |  | 1214517

Mailing Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037
Business Address 1200 PROSPECT STREET SUITE 525 LA JOLLA CA 92037 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

EIN.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38793 | Film No.: 191058185
SIC: 2836 Biological Products, (No Diagnostic Substances)